Endovastec today announced it received registration approval from Japan Pharmaceuticals and Medical Devices Agency for its Hyperflex balloon catheter. The Shanghai-based heart device maker designed Hyperflex to assist in the dilation of aortic stent graft. It is the company's first device approved for marketing in Japan. Hyperflex previously … [Read more...] about Endovastec Hyperflex balloon catheter wins marketing nod in Japan
Endoluxe launches high-definition wireless endoscopy camera
Endoluxe recently launched its high-definition, wireless endoscopic camera with TowerTech. The Manhattan Beach, California-based company designed the Endoluxe eVS for all endoscopic procedures that use industry-standard rigid and flexible analog scopes. Its handheld Orb replaces legacy endoscopic towers for urology, gynecology, ENT, general … [Read more...] about Endoluxe launches high-definition wireless endoscopy camera
This variable stiffness catheter could simplify cardiac procedures
Researchers in Switzerland have developed a variable stiffness catheter that can transition between soft and rigid states. A team of researchers from technical university EPFL and ETH Zurich developed the catheter to make minimally invasive surgical interventions like cardiac arrhythmia treatment, simpler and more effective. Catheters are … [Read more...] about This variable stiffness catheter could simplify cardiac procedures
Artio Medical wins FDA clearance for Solus Gold embolization device
Artio Medical this week announced it received FDA clearance for its Solus Gold embolization device for peripheral vascular occlusion. Solus Gold is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The delivery system uses flexibility and push ability to enable physicians to navigate tortuous … [Read more...] about Artio Medical wins FDA clearance for Solus Gold embolization device
FDA clears Cerus Endovascular 027 microcatheters
Cerus Endovascular this week announced the FDA 510(k) clearance of its 027 microcatheters. Fremont, California-based Cerus Endocascular's new microcatheters are available in two lengths. The company expects to submit for CE mark approval under the EU new Medical Devices Regulation later this year. A limited market release of the 027 … [Read more...] about FDA clears Cerus Endovascular 027 microcatheters
This tentacle-like magnetic robot could navigate the lungs
Engineers at the University of Leeds have developed a magnetic tentacle robot to pass through the narrow tubes of the lungs. Scientists and engineers at the university made a proof of concept for a robotic device that can reach the smallest bronchial tubes to take tissue samples and deliver cancer therapy. The tentacle robot has a diameter of … [Read more...] about This tentacle-like magnetic robot could navigate the lungs
Cathi launches Cathis RHC 2 right heart catheter simulator
German-based endovascular simulator company Cathi recently announced that it launched its Cathis RHC 2 right heart catheter simulator. The company developed Cathis RHC 2 in close consultation with the Cologne Cardiovascular Research Center in Germany. It has all features of the first iteration of the device with added benefits of wire-assisted … [Read more...] about Cathi launches Cathis RHC 2 right heart catheter simulator
Cardiovascular Systems treats first patients using Propel pVAD
Cardiovascular Systems today announced the first in-human procedures using its Propel percutaneous ventricular assist device. The first patients were treated at Piedmont Heart Institute and Cardiovascular Services in Tbilisi, Georgia by Dr. David Kandzari. The St. Paul, Minnesota-based company reported that Propel performed as intended and … [Read more...] about Cardiovascular Systems treats first patients using Propel pVAD
Inari Medical to bring in up to $186.3M in stock offering
Inari Medical (Nasdaq:NARI) announced that it priced an underwritten public offering worth up to $186.3 million in proceeds. Irvine, California-based Inari Medical’s offering includes 2 million shares of its common stock at a public offering price of $81 per share before underwriting discounts and commissions. In addition, the company granted … [Read more...] about Inari Medical to bring in up to $186.3M in stock offering
NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
NeoChord appointed Dr. Martin Leon as executive chair of the company's U.S. early feasibility study of its Transcatheter Nexus system. Leon will be responsible for overseeing and leading the company's initiatives to advance its U.S. regulatory strategy for the Nexus system. He will also guide the company's overall global regulatory strategy as … [Read more...] about NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
